Connect with us
  • Elysium


Rugby study reveals risk of neurodegenerative disease

Risk of dementia is twice as high as general population, rising to up to 15 times as high for MND, shocking new study reveals



rugby players in a scrum with their heads and shoulders down

The risk of neurodegenerative disease among former Scottish international rugby union players is more than double that of the general population, new research has revealed. 

The risk varies by condition, ranging from just over twice as high for dementia, up to 15 times as high for motor neuron disease (MND), the findings show, prompting the researchers to call for strategies to cut the risks of head impact and traumatic brain injury across all sports, including in training.

Traumatic brain injury is a major risk factor for neurodegenerative disease and is thought to account for three per cent of all dementia cases.

The researchers said: “These data add to our understanding of the association between contact sports and lifelong health outcomes, specifically risk of adverse brain health outcomes.

“There remains a need for further research exploring the relationship between contact sports and risk of neurodegenerative disease.

“In the meantime, strategies to reduce exposure to head impacts and head injuries across all sports should continue to be developed and promoted, while measures to mitigate risk of adverse brain health in former athletes should be considered.”

In recent years, post mortem studies of brain tissue have uncovered evidence of neurological disease uniquely associated with a previous history of traumatic brain injury or repetitive head impact exposure – termed chronic traumatic encephalopathy neuropathologic change (CTE-NC)- in former professional athletes from sports, including American football, football and rugby union.

Research including the Drake Rugby Biomarker Study and the BRAIN study has also helped to show the need for urgent action to protect rugby players, with the former highlighting changes in brain structure that can be seen in elite athletes and BRAIN raising concerns around safety standards post-professionalisation.

And in this study, the researchers wanted to find out if the risk of neurodegenerative disease might also be higher among former rugby players than it is among the general population.

They included 412 Scottish former international male rugby players (out of an initial total of 654), for whom full health and field position data were available, and who were aged at least 30 by the end of 2020.

The players were matched for age, sex, and socioeconomic status with 1236 members of the public.

National electronic health record data on hospital admissions, prescription meds, and the most common causes of death among Scottish men – circulatory system disease; respiratory disease; and cancer – were used to track the health and survival of both groups for an average of 32 years from the age of 30 onwards.

During the monitoring period, 121 (29 per cent) of the former rugby players and 381 (31 per cent) of the comparison group died. Former rugby players were older when they died, reaching an average of nearly 79 compared with just over 76 in the comparison group.

And former rugby players had lower rates of death from any cause until they reached the age of 70 after which there was no difference between the two groups.

No differences in cause of, or age at, death were observed between former rugby players and the comparison group for the most common primary causes of death for Scottish men.

But the chance of being diagnosed with a neurodegenerative disease was more than twice as high among the former rugby players (47; 11.5 per cent) than it was among the comparison group (67; 5.5 per cent), although risks varied by condition.

The risk of a dementia diagnosis was just over twice as high, while that of Parkinson’s disease was three times as high, and that of motor neurone disease/amyotrophic lateral sclerosis (ALS) 15 times as high.

Additional analysis showed that field position (forward or back) of the former rugby players had no bearing on neurodegenerative disease risk.

The researchers acknowledge that 37 per cent of former international rugby players who might have been eligible for inclusion in the study had to be excluded in the absence of matched health records, and that the study focused only on men.

Nor was information available on total career length in rugby or history of head impact and traumatic brain injury or on other potential risk factors for dementia.

But the study was relatively large and long term, and the findings echo those of previous studies of former professional soccer players and former American footballers, say the researchers.

“Notably, in contrast to data from the NFL [National Football League] and soccer, our cohort of rugby players largely comprises amateur athletes, although participating at an elite, international level. In this respect, it is the first demonstration that high neurodegenerative disease risk is not a phenomenon exclusive to professional athletes,” the authors point out.

Rugby authorities have taken steps to improve the detection of concussion injuries and to reduce the risks during match play, note the researchers.

“However, head impact exposures and concussion risk are not isolated to match play. As such, measures to reduce exposures in training might also be considered a priority,” they write. 

“In addition to these primary prevention measures, interventions targeted towards risk mitigation among former rugby players with already accumulated head impact exposures might also be considered, including the development of specialist brain health clinics.”